연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
1125. Endoscopic thyroidectomy via bilateral axillo-breast approach (BABA): review of 512 cases in a single institute.
Choi JY, Lee KE, Chung KW, Kim SW, Choe JH, Koo DH, Kim SJ, Lee J, Chung YS, Oh SK, Youn YK.
Surg Endosc. 2011 Nov 4. [Epub ahead of print]
Link
1124. Clinical dissection of multicentric Castleman disease.
Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, Kim DW, Kim I, Yoon SS, Heo DS, Park S, Kim BK
Leuk Lymphoma. 2011 Aug;52(8):1517-22. Epub 2011 May 17.
Link
1123. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging.
Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK.
Ann Surg. 2012 Jan;255(1):50-8.
Link
1122. Prealbumin levels as a useful marker for predicting infectious complications after gastric surgery.
Bae HJ, Lee HJ, Han DS, Suh YS, Lee YH, Lee HS, Cho JJ, Kong SH, Yang HK.
J Gastrointest Surg. 2011 Dec;15(12):2136-44. Epub 2011 Oct 12.
Link
1121. Laparoscopy-assisted distal gastrectomy compared to open distal gastrectomy in early gastric cancer.
Han JH, Lee HJ, Suh YS, Han DS, Kong SH, Yang HK.
Dig Surg. 2011;28(4):245-51. Epub 2011 Jun 3.
Link
1120. The Combined Expression of Metaplasia Biomarkers Predicts the Prognosis Of Gastric Cancer.
Suh YS, Lee HJ, Jung EJ, Kim MA, Nam KT, Goldenring JR, Yang HK, Kim WH.
Ann Surg Oncol. 2011 Nov 3. [Epub ahead of print]
Link
1119. Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ.
Breast Cancer Res. 2011 Mar 2;13(2):R22.
Link
1118. Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.
Im SA, Kim JW, Kim JS, Kim MA, Jordan B, Pickl M, Han SW, Oh DY, Lee HJ, Kim TY, Kim WH, Yang HK, Bang YJ.
Diagn Mol Pathol. 2011 Jun;20(2):94-100.
Link
1117. VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib.
Koh Y, Lee HE, Im SA, Kim SH, Kim TM, Han SW, Oh DY, Kim JH, Lee SH, Kim DW, Kim TY, Kim WH, Heo DS, Bang YJ.
Diagn Mol Pathol. 2011 Sep;20(3):143-7. doi: 10.1097/PDM.0b013e3182107ea0.
Link
1116. Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01.
Im SA, Lee KS, Ro J, Lee ES, Kwon Y, Ahn JH, Ahn JS, Kim JH, Kang HS, Shin KH, Noh DY, Park IA, Kim SB, Im YH, Ha SW.
Breast Cancer Res Treat. 2011 Nov 18. [Epub ahead of print]
Link